O15530 PDPK1_HUMAN
Gene name: PDPK1
Protein name: 3-phosphoinositide-dependent protein kinase 1
List of molecules and drugs that target protein O15530
# | DrugDomain Data | DrugBank Accession | Name | Drug action | Affinity data | InChI Key | SMILES |
---|---|---|---|---|---|---|---|
1 | O15530_DB00482 | DB00482 | Celecoxib | inhibitor | IC50(nM) = 48000.0 | RZEKVGVHFLEQIL-UHFFFAOYSA-N | CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F |
2 | O15530_DB01863 | DB01863 | Inositol 1,3,4,5-Tetrakisphosphate | n/a | CIPFCGZLFXVXBG-CNWJWELYSA-N | O[C@H]1[C@@H](OP(O)(O)=O)[C@H](O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H]1OP(O)(O)=O | |
3 | O15530_DB01933 | DB01933 | 7-Hydroxystaurosporine | n/a | PBCZSGKMGDDXIJ-HQCWYSJUSA-N | [H][C@]12C[C@@H](NC)[C@@H](OC)[C@](C)(O1)N1C3=C(C=CC=C3)C3=C4[C@@H](O)NC(=O)C4=C4C5=C(C=CC=C5)N2C4=C13 | |
4 | O15530_DB01946 | DB01946 | Bisindolylmaleimide VIII | n/a | IC50(nM) = 1000.0 | UQHKJRCFSLMWIA-UHFFFAOYSA-N | CN1C=C(C2=C1C=CC=C2)C1=C(C(=O)NC1=O)C1=CN(CCCN)C2=C1C=CC=C2 |
5 | O15530_DB02010 | DB02010 | Staurosporine | n/a | HKSZLNNOFSGOKW-FYTWVXJKSA-N | [H][C@]1(C[C@@]2([H])O[C@](C)(N3C4=CC=CC=C4C4=C5CNC(=O)C5=C5C6=CC=CC=C6N2C5=C34)[C@]1([H])OC)NC | |
6 | O15530_DB03777 | DB03777 | Bisindolylmaleimide I | n/a | IC50(nM) = 9000.0 | QMGUOJYZJKLOLH-UHFFFAOYSA-N | CN(C)CCCN1C=C(C2=C1C=CC=C2)C1=C(C(=O)NC1=O)C1=CNC2=C1C=CC=C2 |
7 | O15530_DB04522 | DB04522 | Dexfosfoserine | n/a | BZQFBWGGLXLEPQ-REOHCLBHSA-N | N[C@@H](COP(O)(O)=O)C(O)=O | |
8 | O15530_DB06932 | DB06932 | 10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine | n/a | IC50(nM) = 60.0 | NVINUNQBDNEMSY-UHFFFAOYSA-N | COC1=CC2=NC=C3C(N)=NC4=C(C)C(N)=CC=C4C3=C2C=C1OC |
9 | O15530_DB07033 | DB07033 | 5-HYDROXY-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-2-ONE | n/a | VWQVBIPGKIAUGA-QMMMGPOBSA-N | [H][C@](C)(C1=CC=CN1)C1=C2C=C(O)C=CC2=NC1=O | |
10 | O15530_DB07132 | DB07132 | 1-{2-OXO-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-5-YL}UREA | n/a | KJDBLWKTHMHALD-QMMMGPOBSA-N | [H][C@](C)(C1=CC=CN1)C1=C2C=C(NC(N)=O)C=CC2=NC1=O | |
11 | O15530_DB07300 | DB07300 | 2-(1H-imidazol-1-yl)-9-methoxy-8-(2-methoxyethoxy)benzo[c][2,7]naphthyridin-4-amine | n/a | IC50(nM) = 70.0 | QSSGYSRUMIOURP-UHFFFAOYSA-N | COCCOC1=C(OC)C=C2C(=C1)N=CC1=C(N)N=C(C=C21)N1C=CN=C1 |
12 | O15530_DB07456 | DB07456 | 3-(1H-indol-3-yl)-4-(1-{2-[(2S)-1-methylpyrrolidinyl]ethyl}-1H-indol-3-yl)-1H-pyrrole-2,5-dione | n/a | LBFDERUQORUFIN-QGZVFWFLSA-N | [H]N1C=C(C2=CC=CC=C12)C1=C(C(=O)N([H])C1=O)C1=CN(CC[C@H]2CCCN2C)C2=CC=CC=C12 | |
13 | O15530_DB07457 | DB07457 | 3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE | n/a | IC50(nM) = 2000.0 | APYXQTXFRIDSGE-UHFFFAOYSA-N | NCCCN1C=C(C2=C1C=CC=C2)C1=C(C(=O)NC1=O)C1=CNC2=C1C=CC=C2 |
14 | O15530_DB12010 | DB12010 | Fostamatinib | inhibitor | GKDRMWXFWHEQQT-UHFFFAOYSA-N | COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC |